These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29762667)

  • 1. Single Nucleotide Variations of the Human GR Gene Manifested as Pathologic Mutations or Polymorphisms.
    Kino T
    Endocrinology; 2018 Jul; 159(7):2506-2519. PubMed ID: 29762667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.
    Nicolaides NC; Roberts ML; Kino T; Braatvedt G; Hurt DE; Katsantoni E; Sertedaki A; Chrousos GP; Charmandari E
    J Clin Endocrinol Metab; 2014 May; 99(5):E902-7. PubMed ID: 24483153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of Glucocorticoid Signaling.
    Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
    Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel point mutation in helix 10 of the human glucocorticoid receptor causes generalized glucocorticoid resistance by disrupting the structure of the ligand-binding domain.
    Nader N; Bachrach BE; Hurt DE; Gajula S; Pittman A; Lescher R; Kino T
    J Clin Endocrinol Metab; 2010 May; 95(5):2281-5. PubMed ID: 20335448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Analysis on the Pathologic Mutant Glucocorticoid Receptor Ligand-Binding Domains.
    Hurt DE; Suzuki S; Mayama T; Charmandari E; Kino T
    Mol Endocrinol; 2016 Feb; 30(2):173-88. PubMed ID: 26745667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance.
    Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC
    Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1.
    Donner KM; Hiltunen TP; Jänne OA; Sane T; Kontula K
    Eur J Endocrinol; 2013 Jan; 168(1):K9-K18. PubMed ID: 23076843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GENETICS IN ENDOCRINOLOGY: Glucocorticoid resistance syndrome.
    Vitellius G; Lombes M
    Eur J Endocrinol; 2020 Feb; 182(2):R15-R27. PubMed ID: 31995340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.
    Vottero A; Kino T; Combe H; Lecomte P; Chrousos GP
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2658-67. PubMed ID: 12050230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.
    Ruiz M; Lind U; Gåfvels M; Eggertsen G; Carlstedt-Duke J; Nilsson L; Holtmann M; Stierna P; Wikström AC; Werner S
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):363-71. PubMed ID: 11589680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation of the hGR gene causing Chrousos syndrome.
    Nicolaides NC; Geer EB; Vlachakis D; Roberts ML; Psarra AM; Moutsatsou P; Sertedaki A; Kossida S; Charmandari E
    Eur J Clin Invest; 2015 Aug; 45(8):782-91. PubMed ID: 26031419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of the hGRαT556I causing Chrousos syndrome.
    Nicolaides NC; Skyrla E; Vlachakis D; Psarra AM; Moutsatsou P; Sertedaki A; Kossida S; Charmandari E
    Eur J Clin Invest; 2016 Jan; 46(1):42-9. PubMed ID: 26541474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD.
    Roberts ML; Kino T; Nicolaides NC; Hurt DE; Katsantoni E; Sertedaki A; Komianou F; Kassiou K; Chrousos GP; Charmandari E
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E790-5. PubMed ID: 23426617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.
    Kino T; Stauber RH; Resau JH; Pavlakis GN; Chrousos GP
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5600-8. PubMed ID: 11701741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid Resistance.
    Nicolaides NC; Charmandari E
    Exp Suppl; 2019; 111():85-102. PubMed ID: 31588529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the structural basis for glucocorticoid resistance caused by missense mutations in the ligand binding domain of glucocorticoid receptor.
    Monteiro LLS; Franco OL; Alencar SA; Porto WF
    J Mol Graph Model; 2019 Nov; 92():216-226. PubMed ID: 31401440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial/sporadic glucocorticoid resistance syndrome and hypertension.
    Kino T; Vottero A; Charmandari E; Chrousos GP
    Ann N Y Acad Sci; 2002 Sep; 970():101-11. PubMed ID: 12381545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unexpected, mild phenotype of glucocorticoid resistance associated with glucocorticoid receptor gene mutation case report and review of the literature.
    Molnár Á; Patócs A; Likó I; Nyírő G; Rácz K; Tóth M; Sármán B
    BMC Med Genet; 2018 Mar; 19(1):37. PubMed ID: 29510671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ligand binding domain controls glucocorticoid receptor dynamics independent of ligand release.
    Meijsing SH; Elbi C; Luecke HF; Hager GL; Yamamoto KR
    Mol Cell Biol; 2007 Apr; 27(7):2442-51. PubMed ID: 17261597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chrousos syndrome: from molecular pathogenesis to therapeutic management.
    Nicolaides NC; Charmandari E
    Eur J Clin Invest; 2015 May; 45(5):504-14. PubMed ID: 25715669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.